公开(公告)号：WO2012017020A1

公开(公告)日：2012-02-09

申请号：PCT/EP2011/063389

申请日：2011-08-03

Applicant: NOVARTIS AG ,  BRANDL, Trixi ,  FLOHR, Stefanie ,  KOPEC, Sebastian ,  LACHAL, Julie ,  MARKERT, Christian ,  NAMOTO, Kenji ,  NGANGA, Perle ,  PIRARD, Bernard ,  RENATUS, Martin ,  SEDRANI, Richard ,  ZOLLER, Thomas

Inventor： BRANDL, Trixi ,  FLOHR, Stefanie ,  KOPEC, Sebastian ,  LACHAL, Julie ,  MARKERT, Christian ,  NAMOTO, Kenji ,  NGANGA, Perle ,  PIRARD, Bernard ,  RENATUS, Martin ,  SEDRANI, Richard ,  ZOLLER, Thomas

IPC: C07D405/14 ,  C07D403/12 ,  C07D413/12 ,  C07D403/14 ,  C07D417/14 ,  C07D409/14 ,  A61K31/4439 ,  A61P7/02

CPC classification number: C07D409/14 ,  C07D403/12 ,  C07D403/14 ,  C07D405/14 ,  C07D413/12 ,  C07D417/14

Abstract: The invention relates to compound of the formula (I) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

Abstract translation: 本发明涉及式（I）化合物，其中取代基如说明书中所定义; 以游离形式或盐形式; 作为其制备，用作药物和包含它的药物。